Stay updated on Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Footer updates include adding a 'Revision: v3.3.3' notice and removing the 'HHS Vulnerability Disclosure' link as well as 'Revision: v3.3.2'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T10:22:28.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2 in the page footer; no substantive changes to the study content or details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:22:03.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Added a note that Publications are auto-filled from PubMed and may not reflect the study, and updated the page revision to v3.3.1; the prior PubMed note and v3.2.0 revision were removed.
    Difference
    0.1%
    Check dated 2025-11-24T13:39:37.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Removed an administrative notice about government funding and NIH operating status; the study details, eligibility, and outcomes sections remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:30:18.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The update appears non-substantive, reflecting a refreshed last-updated timestamp and minor UI adjustments without changing core study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:10:55.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    Core content updated to include an official operating-status notice and new version (v3.2.0); the previous version tag (v3.1.0) was removed.
    Difference
    3%
    Check dated 2025-10-05T09:34:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page.